beta-interferon
Noun A type of interferon, a signaling protein, that is produced by fibroblasts (connective tissue cells). It has antiviral properties and is used as a therapeutic agent in the treatment of multiple sclerosis.
"Beta-interferon" is a specific, technical term used primarily in medical and pharmaceutical contexts. It refers to the pharmaceutical preparation itself, not the general biological concept of interferon. * The doctor prescribed beta-interferon to help manage the patient's relapsing-remitting multiple sclerosis. * Research into beta-interferon focuses on its immunomodulatory effects.
- The term is often used in discussions of disease-modifying therapies (DMTs) for multiple sclerosis.
- It may be specified further by brand or formulation names (e.g., interferon beta-1a, interferon beta-1b), which are considered distinct pharmaceutical products.
- Interferon beta-1a: A specific recombinant form of beta-interferon.
- Interferon beta-1b: Another specific recombinant form of beta-interferon.
- Interferon: The broader class of proteins to which beta-interferon belongs.
- IFN-β (Abbreviation)
- Interferon-beta
This is a highly specialized term with no common idioms, phrasal verbs, or casual usage. Its meaning is fixed within the scientific and medical lexicon.
- a form of interferon that is produced by fibroblasts and have antiviral effects; used in the treatment of multiple sclerosis